Skip to main content

Advertisement

SpringerLink
Log in

Risk Factors for Re-recurrence After First Reoperative Surgery for Locoregional Recurrent/Persistent Papillary Thyroid Carcinoma

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Papillary thyroid carcinoma (PTC) is generally an indolent tumor indicative of favorable prognosis. However, post-treatment recurrences may be problematic, and management strategies for recurrent disease have not been established. This study investigated risk factors associated with re-recurrence of PTC after reoperative surgery.

Materials and methods

This study included 151 patients with pathologically confirmed recurrent/persistent PTC who underwent reoperation. Clinical factors, operative and pathologic findings, serum thyroglobulin levels, postoperative complications, and recurrences were examined. Univariate and multivariate analyses were performed to identify factors associated with re-recurrence-free survival (RFS) after reoperative surgery.

Results

Recurrent tumors were found in thyroid remnants or previous resection bed (n = 28), central nodes (n = 48), and lateral neck nodes (n = 102). Biochemical complete remission (stimulated thyroglobulin <1 ng/mL) was achieved in 69 (51.5 %) patients after reoperative surgery. Permanent vocal fold paralysis and hypoparathyroidism developed in 6 (4.1 %) and 4 (2.8 %) patients, respectively. Vocal fold paralysis occurred primarily due to intentional nerve resection following tumor invasion. During a median follow-up of 57.5 months, 41 (27.2 %) patients had re-recurrences. Univariate analyses showed that extranodal extension (p = 0.028), recurrent laryngeal nerve invasion (p = 0.037), as well as stimulated (p = 0.001) and unstimulated (p = 0.015) serum thyroglobulin were significant predictors of RFS. Multivariate analyses showed that postoperative biochemical remission independently predicted RFS (p = 0.014).

Conclusions

Postoperative thyroglobulin after reoperative surgery predicted re-recurrence. Careful follow-up of these patients after reoperation is recommended.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Shaha AR, Shah JP, Loree TR (1996) Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. Am J Surg 172(6):692–694

    Article  CAS  PubMed  Google Scholar 

  2. Lee CW, Roh JL, Gong G et al (2014) Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck. Ann Surg Oncol. 22(1):117–124

    Article  PubMed  Google Scholar 

  3. Randolph GW, Duh QY, Heller KS, American Thyroid Association Surgical Affairs Committee’s Taskforce on Thyroid Cancer Nodal Surgery et al (2012) The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 22(11):1144–1152

    Article  PubMed  Google Scholar 

  4. Kim SJ, Park SY, Lee YJ et al (2014) Risk factors for recurrence after therapeutic lateral neck dissection for primary papillary thyroid cancer. Ann Surg Oncol 21(6):1884–1890

    Article  PubMed  Google Scholar 

  5. Ito Y, Kudo T, Kobayashi K et al (2012) Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up. World J Surg 36(6):1274–1278. doi:10.1007/s00268-012-1423-5

    Article  PubMed  Google Scholar 

  6. Lundgren CI, Hall P, Dickman PW et al (2006) Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 106(3):524–531

    Article  PubMed  Google Scholar 

  7. Ito Y, Higashiyama T, Takamura Y et al (2011) Prognosis of patients with papillary thyroid carcinoma showing postoperative recurrence to the central neck. World J Surg 35(4):767–772. doi:10.1007/s00268-010-0924-3

    Article  PubMed  Google Scholar 

  8. Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97(5):418–428

    Article  CAS  PubMed  Google Scholar 

  9. Kim MK, Mandel SH, Baloch Z et al (2004) Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg 130(10):1214–1216

    Article  PubMed  Google Scholar 

  10. Roh JL, Kim JM, Park CI (2011) Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence. Ann Surg Oncol 18(8):2245–2250

    Article  PubMed  Google Scholar 

  11. Al-Saif O, Farrar WB, Bloomston M et al (2010) Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer. J Clin Endocrinol Metab 95(5):2187–2194

    Article  CAS  PubMed  Google Scholar 

  12. Yim JH, Kim WB, Kim EY et al (2011) The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation. J Clin Endocrinol Metab 96(7):2049–2056

    Article  CAS  PubMed  Google Scholar 

  13. Hughes DT, Laird AM, Miller BS et al (2012) Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin. Ann Surg Oncol 19(9):2951–2957

    Article  PubMed  Google Scholar 

  14. Schuff KG, Weber SM, Givi B et al (2008) Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer. Laryngoscope 118(5):768–775

    Article  PubMed  Google Scholar 

  15. Lang BH, Wong KP, Wan KY (2013) Postablation stimulated thyroglobulin level is an important predictor of biochemical complete remission after reoperative cervical neck dissection in persistent/recurrent papillary thyroid carcinoma. Ann Surg Oncol 20(2):653–659

    Article  PubMed  PubMed Central  Google Scholar 

  16. McCaffrey TV, Lipton RJ (1990) Thyroid carcinoma invading the upper aerodigestive system. Laryngoscope 100(8):824–830

    Article  CAS  PubMed  Google Scholar 

  17. Johnson S, Goldenberg D (2008) Intraoperative monitoring of the recurrent laryngeal nerve during revision thyroid surgery. Otolaryngol Clin North Am 41(6):1147–1154

    Article  PubMed  Google Scholar 

  18. Sippel RS, Elaraj DM, Poder L et al (2009) Localization of recurrent thyroid cancer using intraoperative ultrasound-guided dye injection. World J Surg 33(3):434–439. doi:10.1007/s00268-008-9797-0

    Article  PubMed  Google Scholar 

  19. Wada N, Duh QY, Sugino K et al (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237(3):399–407

    PubMed  PubMed Central  Google Scholar 

  20. Roh JL, Park JY, Park CI (2007) Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg 245(4):604–610

    Article  PubMed  PubMed Central  Google Scholar 

  21. Robbins KT, Shaha AR, Medina JE et al (2008) Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg 134(5):536–538

    Article  PubMed  Google Scholar 

  22. Olson JA Jr, DeBenedetti MK, Baumann DS et al (1996) Parathyroid autotransplantation during thyroidectomy. Results of long-term follow-up. Ann Surg 223(5):472–478

    Article  PubMed  PubMed Central  Google Scholar 

  23. Cooper DS, Doherty GM, Haugen BR, American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11):1167–1214

    Article  PubMed  Google Scholar 

  24. Kim TY, Kim WB, Kim ES et al (2005) Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 90(3):1440–1445

    Article  CAS  PubMed  Google Scholar 

  25. Honaker J, King G, Blackwell M (2011) Amelia II: a program for missing data. J Stat Softw 45(7):1–47. http://www.jstatsoft.org/v45/i07/

  26. Pitoia F, Bueno F, Urciuoli C et al (2013) Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American thyroid association and Latin American thyroid society risk of recurrence classification systems. Thyroid 23(11):1401–1407

    Article  PubMed  Google Scholar 

  27. Shim MJ, Roh JL, Gong G et al (2013) Preoperative detection and predictors of level V lymph node metastasis in patients with papillary thyroid carcinoma. Br J Surg 100(4):497–503

    Article  CAS  PubMed  Google Scholar 

  28. Lango M, Flieder D, Arrangoiz R et al (2013) Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression. Thyroid 23(9):1099–1105

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This study was supported by a Grant (No. 2014-0306) from the Asan Institute for Life Science, Seoul, Korea (J.-L. Roh).

Conflict of interest

The authors have no conflicts of interest to declare.

Author information

Authors and Affiliations

  1. Department of Otolaryngology, Asan Medical Centre, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Republic of Korea

    Hwan Seo Lee, Jong-Lyel Roh, Seung-Ho Choi, Soon Yuhl Nam & Sang Yoon Kim

  2. Department of Pathology, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, Republic of Korea

    Gyungyup Gong & Kyung-Ja Cho

  3. Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, Republic of Korea

    Sang Yoon Kim

Authors
  1. Hwan Seo Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jong-Lyel Roh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gyungyup Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kyung-Ja Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Seung-Ho Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Soon Yuhl Nam
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sang Yoon Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jong-Lyel Roh.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, H.S., Roh, JL., Gong, G. et al. Risk Factors for Re-recurrence After First Reoperative Surgery for Locoregional Recurrent/Persistent Papillary Thyroid Carcinoma. World J Surg 39, 1943–1950 (2015). https://doi.org/10.1007/s00268-015-3052-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-015-3052-2

Keywords

Search

Navigation